TARGETWATCH
DEDevyser
Seneste kurs
65,30 SEK
22.7.2026
Seneste
90,00 SEK
+37.83%
Opside
DVYSR
3 mdr.+37,83%1 kursmål
6 mdr.+94,49%2 kursmål
1 år+94,49%2 kursmål
Max 4 kursmål
Pareto Securities
SundhedMedical Devices

Om selskabet

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Yahoo Finance

Seneste kursmål

Kursmål
90,00 SEK
Opside
+37,83%
Seneste kurs65,30 SEK

Insiderhandel for Devyser

Køb
May 2297K SEKJan WahlströmAdm. direktør
Køb
May 21190K SEKJan WahlströmAdm. direktør

Flere kursmål for Devyser

Dato
Jul 21
Kursmål
90,00 SEK

Analytiker
Dato
Feb 13
Kursmål
164,00 SEK

Analytiker
Dato
Jul -25
Kursmål
190,00 SEK

Analytiker
Dato
Jul -25
Kursmål
150,00 SEK